Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Dobesilate vs Coasting for OHSS Prevention
NCT02290002Phase 3Completed
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcium dobesilate in ovarian hyperstimulation syndrome (OHSS). Started Jun 2014; status: completed.
02
Drugs
calcium dobesilate
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02290002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290002.